Bipolar disorder, also called manic-depressive disorder, is a mental disorder that causes unusual mood swings in patients. The disease causes periods of depression and mania in patients.The market encompasses drugs for the treatment of manic and depressive episodes.The major drug classes included in the report are antipsychotics, anticonvulsants,mood stabilizers, and other drugs such as antidepressants and antianxiety drugs.The global bipolar disorder therapeutic market is expected to benefit from the rising awareness of the disease, which is increasing the diagnosis rate. The major drug classes included in the treatment of bipolar disorder are antipsychotics,anticonvulsants, mood stabilizers, and other drugs such as antidepressants and antianxiety drugs.

PART 01: Executive summary 6

PART 02: Scope of the report 17

PART 03: Research Methodology 22

PART 04: Introduction 25

Key market highlights 25

PART 05: Disease overview 26

PART 06: Market landscape 29

Market overview 29

Market size and forecast 30

Five forces analysis 32

PART 07: Pipeline landscape 33

PART 08: Market segmentation by drug class 35

Market overview 35

Antipsychotics 36

Anticonvulsants 37

Traditional mood stabilizers 40

Others 41

PART 09: Geographical segmentation 43

Bipolar disorder therapeutics market in Americas 44

Bipolar disorder therapeutic market in EMEA 46

Bipolar disorder therapeutic market in APAC 48

PART 10: Decision framework 50

PART 11: Drivers and challenges 52

Market drivers 53

Impact of drivers on key customer segments 56

Market challenges 57

Impact of challenges on key customer segments 60

PART 12: Market trends 61

Awareness about bipolar disorder in children (pediatric

extension) 61

Rising application of combination therapies 61

PART 13: Vendor landscape 63

Competitive scenario 63

PART 14: Key vendor analysis 65

Eli Lilly 65

Bristol-Myers Squibb 68

AstraZeneca 71

Other prominent vendors 73

PART 15: Appendix 75

List of abbreviations 75

PART 16: Explore Technavio 76